The US health department is reviewing the Centers for Disease Control and Prevention’s (CDC) HIV prevention division for potential overlap with other agencies, raising concerns among activists about its future.
The Department of Health and Human Services (HHS) said it was looking at all divisions for potential overlap as part of Trump’s broader efforts to restructure the federal government. However, no final decision has been made on the CDC’s HIV Prevention Division.
The division, which costs $1.3 billion annually, tracks infections across the US and promotes testing and prevention. Its funding is uncertain amid the Trump administration’s government restructuring.
HIV activists are campaigning against potential dismantling of the division, citing its importance in preventing new infections. “It’s essential that we get the message out that HIV prevention is crucial,” said Jesse Milan, CEO of AIDS United. “The funding for this division saves lives.”
If the division were to be dismantled, significant cuts would likely occur, putting vulnerable populations at risk. There are currently 1.2 million people who are vulnerable to HIV infection, and the division plays a critical role in preventing these infections.
AIDS activists are urging elected representatives to take action, as the Trump administration’s approach to HIV/AIDS policy is undergoing a broad shift. The White House recently halted the distribution of HIV medications by US-funded foreign clinics, disrupting treatment for millions worldwide.
The review of the CDC’s HIV Prevention Division is ongoing, and no final decision has been made. However, activists are urging caution and warning that any changes could have significant consequences for public health.
Source: https://www.reuters.com/business/healthcare-pharmaceuticals/trump-administration-weighing-future-cdcs-hiv-prevention-division-2025-03-18